Journal
BLOOD
Volume 139, Issue 2, Pages 154-155Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021013964
Keywords
-
Categories
Ask authors/readers for more resources
In this study, a novel PET radio tracer was used to assess residual disease in MALT lymphoma after first-line Helicobacter pylori eradication.
In this issue of Blood, Mayerhoefer et al(1) report the use of a novel PET radio tracer targeting the G-protein-coupled C-X-C chemokine receptor type 4 (CXCR4), for assessment of residual disease in gastric mucosa-associated lymphoid tissue (MALT) lymphoma after first-line Helicobacter pylori eradication.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
